ARCHIVES

Abraxane-Gemcitabine Combination Extends Overall Survival in Phase III Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 1 | January 31, 2014

Download PDF Visit The Full Archive

Related Articles

NCI Reportedly Gets $691 Million From House, Senate Conferees

October 4, 1974

Strategic Plan Identifies Goal; To Be The Authoritative Source For Cancer Information

May 21, 1999

“We Want Our Voices To Be Heard” Coalition Tells NCAB; Seeks Seats On Advisory Board

January 1, 1993

ODAC Clarifies Standards for Maintenance In Ovarian Cancer; Nixes Olaparib in 11-2 Vote

June 27, 2014

Copeland Named Director, UF Cancer Center

February 10, 1995

NCCF, Ad Council plan public service ads on childhood cancer.

November 7, 2003